2011 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

��ɫ��

2011 Annual Meeting | Attention Deficit Hyperactivity Disorder Across the Lifespan

Date Wednesday 04/13/11

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Max Wiznitzer, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should be able to recognize the clinical features of ADHD during key ages in the lifespan; understand the neurobiological basis and core neuropsychologic underpinnings of ADHD and their impact on clinical manifestations; know the available treatment options (pharmacologic and nonpharmacologic) for ADHD and common comorbid conditions at various ages; and determine treatment options when ADHD co-occurs with neurologic conditions such as tic disorder and epilepsy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Event Timeline
06:30 AM - 06:50 AM		Diagnosis and Assessment of ADHD Max Wiznitzer, MD, FAAN
06:30 AM - 08:30 AM		Break
06:50 AM - 07:10 AM		Neuroscience and Basis for Treatment Max Wiznitzer, MD, FAAN
07:10 AM - 07:35 AM		Pharmacological Treatment of ADHD Max Wiznitzer, MD, FAAN
07:35 AM - 08:10 AM		Nonpharmacological Treatment of ADHD: Behavioral Intervention Revisited Michael Manos, PhD
08:10 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.
Michael Manos, PhD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��